Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines

The WHO emergency use-listed (EUL) COVID-19 vaccines were developed against early strains of SARS-CoV-2. With the emergence of SARS-CoV-2 variants of concern (VOCs) - Alpha, Beta, Gamma, Delta and Omicron, it is necessary to assess the neutralizing activity of these vaccines against the VOCs. PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukhopadhyay, Labanya, Gupta, Nivedita, Yadav, Pragya D., Aggarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552365/
https://www.ncbi.nlm.nih.gov/pubmed/35859437
http://dx.doi.org/10.4103/ijmr.ijmr_2544_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552365/
https://www.ncbi.nlm.nih.gov/pubmed/35859437
http://dx.doi.org/10.4103/ijmr.ijmr_2544_21

Ejemplares similares